Induction of hyporesponsiveness in human lymphocytes-T despite their expression of both the co-receptor CD28 and its ligand B7

Cell Immunol. 1993 Oct 15;151(2):283-90. doi: 10.1006/cimm.1993.1238.

Abstract

A majority (42/62) of TCR2+ interleukin 2-dependent human T lymphocyte clones was found concordantly to express not only the CD28 co-receptor structure at the cell surface but also its ligand B7. Interactions between CD28 and B7 can have important consequences for T cell activation, particularly in providing "signal 2" to prevent the induction of anergy caused by stimulation via the antigen receptor only ("signal 1"). However, despite the expression of co-receptor and ligand on the same cell surface, it remained possible to induce hyporesponsiveness in T cell clones either when using CD3 antibodies to deliver signal 1 or when using other T cell clones as stimulators. Thus, the potential for intraclonal autostimulation via CD28/B7 is apparently insufficient to prevent downregulation of responsiveness in these two systems.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • B7-1 Antigen / biosynthesis*
  • CD28 Antigens / biosynthesis*
  • CD3 Complex / immunology
  • Clonal Anergy / immunology*
  • Clone Cells
  • HLA-D Antigens / immunology
  • Humans
  • Lymphocyte Activation / immunology
  • Muromonab-CD3
  • T-Lymphocytes / immunology*

Substances

  • Antibodies, Monoclonal
  • B7-1 Antigen
  • CD28 Antigens
  • CD3 Complex
  • HLA-D Antigens
  • Muromonab-CD3